Trials / Completed
CompletedNCT06411535
Impact of Ultra-Processed Food Intake on Gingival Tissue Health
Impact of Ultra-Processed Food Intake on Gingival Tissue Health: A Pre-post Clinical Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 66 (actual)
- Sponsor
- University of Siena · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The shift towards consuming more industrialized food products, particularly ultra-processed foods, has been linked to a rise in non-communicable diseases globally. These products are energy-dense, high in unhealthy components, and often lead to overconsumption due to their palatability and convenience. Studies suggest a connection between ultra-processed food consumption and various health issues, including obesity and cardiovascular diseases. The present study is designed as a single-center, double-blind, parallel-arm randomized clinical trial. This study aims to investigate the impact of ultra-processed food consumption on gingival health and to evaluate the potential benefits of dietary counseling and reduced ultra-processed food intake on gingival inflammation over a 4-month period.
Detailed description
The impact of shifting of a diet from less industrialized food products toward a more industrialized food products has a positive relationship to the global burden of non- communicable disease. This increase in the consumption of Ultra-Process food was first started in the high-income countries and now in medium-income countries. All together, they are energy dense, high in unhealthy types of fat, refined starches, free sugars and salt, and poor sources of protein, dietary fibre. Ultra-processed products are made to be hyper-palatable and attractive, with long shelf-life and able to be consumed anywhere, any time. Their formulation, presentation and marketing often promote overconsumption. Due to the high levels of additives, sugars and preservatives, they have been associated with various non-communicable diseases, including obesity, cardiovascular diseases and systemic inflammation like periodontitis. In order to investigate a relationship between ultra-process food consumption and gingival health we used a food frequency questionnaire conducted and evaluated in a study in south of Italy with the classification of food according to the NOVA classification. In recent years the effect of ultra-processed foods consumption on systemic and oral health has received more attention. Several studies have reported a significant association between caries and ultra-processed food. However, the effect of an highly processed food diet on gingival tissues health has not been fully investigated. Thus, the aim of the present study is to assess the impact of ultra-processed food consumption on gingival inflammation Primary Objective: To assess the association between ultra-processed food intake and the health of gingival tissues of a University-based cohort of individuals Secondary Objectives: To determine the role of dietary counselling and reduced ultra-processed food consumption on the resolution of gingival inflammation. Trial design The current protocol is designed as single-centre, double-blind, parallel arm, University-based, superiority, clinical trial with a 4-month follow up.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Full-mouth ultrasonic debridement plus Nutritional counseling | After diagnosis of gingivitis, patients will receive a nutritional counseling focused on ultra-processed foods entails educating individuals about the nutritional content and potential health implications of highly processed food products. They will undergo a session of full-mouth ultrasonic debridement and reinforcment of dietary counseling. Between consecutive time points, patients will receive motivational emails. |
| OTHER | Full-mouth ultrasonic debridement | After diagnosis of gingivitis, patients will receive a session of full mouth ultrasonic debridement |
Timeline
- Start date
- 2024-05-21
- Primary completion
- 2024-10-28
- Completion
- 2024-10-28
- First posted
- 2024-05-13
- Last updated
- 2024-10-30
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT06411535. Inclusion in this directory is not an endorsement.